DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology

0
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...

Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.

0
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....

Popular News

Journal of Neuroscience Didn’t Find Data Manipulation Evidence in Research Article...

0
Cassava Sciences Inc. (NASDAQ: SAVA) has received communication from the Journal of Neurosciences that the research article published in July 2021  proposing a new...

MAKE IT MODERN

LATEST REVIEWS

Amicus Therapeutics (NASDAQ:FOLD) Announce Encouraging Preliminary AT-GTX-501 Gene Therapy Results In...

0
Amicus Therapeutics (NASDAQ:FOLD) has announced more positive preliminary data from the CLN6 Batten disease gene therapy program, AT-GTX-501. Amicus presents AT-GTX-501 results The released results were...

MAKE IT MODERN

PERFORMANCE TRAINING

VBI Vaccines Inc. (NASDAQ:VBIV) Submits MAA In Europe And BLA In The US For...

0
VBI Vaccines Inc. (NASDAQ:VBIV) has submitted a Marketing Authorization Application (MAA) for its 3-antigen prophylactic hepatitis B vaccine candidate to the European Medicines Agency....

Small cap with large potential (RBLX, SNOW, ALGN)

0
Roblox Corp (NYSE:RBLX) - Roblox (RBLX) has had a nice bounce off a major support level. The stock was significantly sold off...

Royalty Pharma Plc (NASDAQ:RPRX) Shares Surge Over 60% Following Successful IPO

0
Royalty Pharma Plc (NASDAQ:RPRX) shares surged 59% after it made its trading debut following an upsized IPO, which braised $2.18 billion with top of...

Dyne Therapeutics Inc. (NASDAQ: DYN) Receives Clinical Hold From FDA Regarding IND for...

0
Dyne Therapeutics Inc.  (NASDAQ: DYN) has announced that the US FDA has put a clinical hold on its Investigational New Drug application...

MannKind Corporation (NASDAQ: MNKD) Plunges 29% after FDA Rejects NDA for Tyvaso DPI in...

0
MannKind Corporation (NASDAQ: MNKD) has discovered that the US FDA has issued a complete response to United Therapeutics about Tyvaso DPI’s New Drug Application...

MAKE IT MODERN

POPULAR

romabet mahbet پین باهیس bettingmagazine.org بت کارت یاس بت yekbet megapari onjabet alvinbet betboro betfa بت فوروارد 1xbet 1win betwinner 4shart.com 1xbetgiris.cam وان کیک بت وین بت ریتزوبت 1xbet-ir.com.co وان ایکس بت بت فوروارد